Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01KIC
|
|||
| Former ID |
DIB014782
|
|||
| Drug Name |
ORV-116E
|
|||
| Synonyms |
Rotavac; Rotavirus vaccine, Bharat; 116E
Click to Show/Hide
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 3 | [1] | |
| Company |
Bharat Biotech International Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01305109) A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.